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ABSTRACT. Acridine ring can be found in molecules used in many different spheres, 
including industry and medicine. Nowadays, even acridines with antibacterial activity are 
of research interest due to increasing bacterial resistance. Some acridine derivatives 
showed antimalarial or antiviral activity. Acridine derivatives were also investigated for 
antitumor activity due to the interaction with topoisomerase II and DNA base pairs. 
Considering these possible uses of acridine derivatives, this work was made as overview 
of all significant structure characteristics for specific action of these compounds. 
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INTRODUCTION 
 
Acridines are compounds known ever since 19th century. When these substances were 
isolated from crude anthracene, one of them was named acridine (acridine means sharp, 
painful) since it had itching and inflammatory properties (REINHARDT and TRAVIS, 2000). 
Correct structure of acridine was established by Carl Riedel, who also established acridine, 
quinoline and pyridine structure relationships. Almost at the same time, acridine was 
successfully synthesized (REINHARDT and TRAVIS, 2000). Structure of acridine and its 
numeration are shown in Fig. 1 (GRAEBE and LAGODZINSKI, 1893). Acridine can also be 
named as 10-azaanthracene and dibenzo[b,e]pyridine.  
 
 
 
Figure 1. Acridine structure and numeration. 
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Acridine ring can be found in molecules used in many different spheres, including 
industry and medicine (ALBERT, 1966; BROWNING, 1937; BROWNING, 1964). 
Acridine derivatives, such as acriflavine and proflavine, were used during the World 
War I as topical antibacterial agents. Later, quinacrine was discovered and used during 
World War II as antimalarial agent (NASIM and BRYCHCY, 1979). Chemical structures of 
these acridine derivatives are presented in Fig. 2. 
 
 
 
Figure 2. Chemical structure of several acridine derivatives: 
A) acriflavine; B) proflavin; C) quinacrine. 
 
 
Soon after World War II, penicillines and other antibiotics replaced acridine based 
drugs with antibacterial properties. However, other acridine derivatives which had different 
targets were still in use. Nowadays, even acridines with antibacterial activity are of research 
interest due to increasing bacterial resistance (KUMAR et al., 2012). 
During 1980s, many antitumor drugs which were in clinical trials or in clinical use 
actually interacted with DNA. One of those derivatives was 4’-(9-
acridinylamino)methanesulphon-m-anisidide (m-AMSA) (Fig. 3). m-AMSA was developed 
as a result of SAR study conducted on sulfonanilide ring substituted compounds (CAIN et 
al., 1975). These authors used murine L1210 leukemia cells as a test system, while 
BAGULEY and NASH (1981) showed later good correlation between in vitro and in vivo 
antitumor activity using the same cells. 
 
 
 
Figure 3. Chemical structure of m-AMSA. 
 
 
ROWE et al. (1986) proved theory that activity of DNA topoisomerase II may be 
affected by antitumor acridines, including m-AMSA. Several other groups of acridine 
derivatives also have antibacterial (BROWNING et al., 1922; ALBERT et al., 1949) and 
antitumor activity (JIANG et al., 2016; CUI et al., 2016). 
Some acridine derivatives showed antimalarial activity (CHAVALITSHEWINKOON et al., 
1993; COGGESHALL, 1952). According to CHAVALITSHEWINKOON et al. (1993), 9-
anilinoacridines with specific substituents inhibited the decatenation activity of Plasmodium 
falciparum DNA topoisomerase II. 
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SUVEYZDIS et al. (2000) published a research which confirmed that some aminoacridine 
derivatives possess antiviral activity. 
 
 
ACRIDINE-DNA INTERACTIONS 
 
Acridine derivatives can interact with DNA by intercalating between DNA base pairs 
(PEACOCKE and SKERRETT, 1956; RAMSTEIN et al., 1972; GEORGHIOU, 1975). The interaction 
of acridine with DNA was also evaluated by CHOUDHURY and BASU (1995), using absorption 
and fluorescence spectroscopy. DNA based electrochemical biosensors were successfully 
used for investigation of interactions between DNA and other molecules (DICULESCU et al., 
2016; ALEKSIĆ and KAPETANOVIĆ, 2013; ALEKSIĆ and KAPETANOVIĆ, 2014), such as proteins 
(ŽIVANOVIĆ et al., 2010) and different drugs (RADULOVIĆ et al., 2012a; RADULOVIĆ et al., 
2012b; PANTIĆ et al., 2016; LIJESKIĆ et al., 2014).  
Different electrodes may be used in voltammetric methods with aim to prove 
electroactivity of compounds containing acridine ring (GIROUSI et al., 2008; PONTINHA et al., 
2013). PANTIĆ et al. (2016) proved interaction of 9-chloroacridine with double-stranded calf 
thymus DNA using square wave voltammetry and DNA-modified glassy carbon electrode. 
 
 
ANTIPARASITIC ACTIVITY OF ACRIDINE DERIVATIVES 
 
Antimalarial activity of acridine derivatives is based on several mechanisms of action: 
hemozoin targeting (KUMAR et al., 2007), DNA topoisomerase inhibition (FERGUSON and 
DENNY, 2007; CHAVALITSHEWINKOON et al., 1993), folate metabolism inhibition (SANTELLI-
ROUVIER et al., 2004) and plasmepsin II inhibition (AZIM et al., 2008). 
SANTELLI-ROUVIER et al. (2004) synthesized arylacridinylsulfones which showed 
activity against Plasmodium falciparum. These compounds (Fig. 4) showed activity due to 
structural similarity with dapsone and its derivatives (POPOFF et al., 1971) or acridine 
derivatives (FIGGITT et al., 1992). According to SANTELLI-ROUVIER et al., activities were not 
dependent on the presence of para-aminobenzoic acid (PABA) and acridine ring was part of 
the compounds responsible for the particular antimalarial activity. The sulfone group is also 
important for their activity. These authors suggested that there might be relationship between 
the activity and the ability of cleavage of the S-9C bond in acridine compound structure. 
AZIM et al. (2008) used virtual screening for identification of acridine derivatives 
which may have significant activity against P. falciparum. They showed that potency was 
improved, and selective aspartic protease activity was achieved with different substituents 
(Fig. 5). 
YU et al. (2012) synthesized new N-alkylaminoacridine derivatives (Fig. 6) with 
heterocyclic ring in the position C9 which significantly increased the activity against P. 
falciparum. Compounds with chloro and methoxy substituents in the acridine structure had 
higher inhibitory activity on the β-hematin formation, but inhibition was not in correlation 
with antimalarial activity. Morpholinyl compounds showed modest activity and also were 
highlighted for antimalarial activity by other authors (OPSENICA et al., 2011). 
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Figure 4. Arylacridinyl sulfones. 
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Figure 5. Acridinyl derivatives with selective aspartic protease activity. 
 
 
 
Figure 6. Acridine derivatives proposed to have antimalarial activity  
or activity against β-hematin formation. 
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ANTIVIRAL ACTIVITY OF ACRIDINE DERIVATIVES 
 
Series of acridinylaminoalcohols and acridinylaminoacid esters were syntesized and 
their activity against herpes simplex virus (HSV) was investigated (SUVEYZDIS et al., 2000). 
Maximum activity was established with compounds Ia and Ic. Compounds IIa - IId, as well as 
reference drugs (camedone and amyxin) were inactive. Also, the authors annotated the 
inversion of relative activity of enantiomers (compounds Ic and Id) on passage from the in 
vivo to the in vitro model. 
 
 
 
Figure 7. Structures of synthesized acridinylaminoalcohols (I),  
acridinylaminoacid esters (II), camedone and amyxin. 
 
Compounds presented in Fig. 7 were of interest for new antiviral acridine derivatives 
research. 
GOODELL et al. (2006) also examined anti-herpes activity of a group of acridine 
derivatives. They suggested that some derivatives (Fig. 8) interrupt enzyme/DNA interaction 
due to their capacity to intercalate DNA. Their anti-herpes activity is in correlation with 
catalytic inhibition of topoisomerase II, but some acridines which haven’t showed activity in 
the topoisomerase II relaxation assay still had anti-herpes activity. This may be explained 
with non-specific binding of the acridines by intercalation. Acridine substituents affect 
electronic or steric properties of these compounds and thus cause different binding tendency. 
The carboxamides which contain diethylamine in C2 and C3 positions had the highest 
activity. Acridine derivatives with carboxamide in C2 and C3 positions and bulky 9-amino 
groups inhibited herpes infections. 
ARTUSI et al. (2015) conducted research on HSV-1 genome and evidenced extended 
G-quadruplex sites. They suggested that replication of HSV DNA may be stopped by G-
quadruplex ligands, such as BRACO-19 (Fig. 9). BRACO-19 is a 3,6,9-trisubstituted acridine 
derivative which stabilizes G-quadruplex (READ et al., 2001), inhibits telomerase activity 
(HARRISON et al., 2003) and has antitumor activity (BURGER et al., 2005). 
PEPIN et al. (2017) used sub-toxic concentrations of acriflavine and proflavine mixture 
to encourage a cyclic-GMP-AMP (cGAMP) synthase (cGAS)-dependent type-I IFN antiviral 
response. This mixture reduced rhinovirus infection. These compounds showed antiviral 
effects in mammalian cells as indirect antagonists of cGAS. 
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Figure 8. Acridine derivatives with anti-herpes activity. 
 
 
 
 
Figure 9. Chemical structure of BRACO-19. 
 
 
 
ANTIBACTERIAL ACTIVITY OF ACRIDINE DERIVATIVES 
 
STEWART (1973) synthesized derivatives of acridine with carbamic and thiocarbamic 
acid esters, urea and thiourea substituents at C9 (Fig. 10). Compounds containing thiourea 
group (I and II) showed antibacterial activity against Staphylococcus aureus, Proteus 
vulgaris, Salmonella pullorum, Salmonella typhimurium, Escherichia coli, Klebsiella 
pneumoniae and Diplococcus pneumoniae. Compound II inhibited also Proteus mirabilis, 
Streptococcus pyogenes and Pasteurella multocida. 
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Figure 10. Chemical structures of acridine derivatives with thiourea substituents at C9  
evaluated for antibacterial activity. 
 
ALBERT (1966) conducted research on antibacterial activity of acridines and found 
parameters obligatory for this activity. These parameters include cation formation, high levels 
of ionization at neutral pH and planar molecule surface area. Electronic conjugation between 
nitrogen atom in acridine ring and amino group and resulting ionization were responsible for 
their high activity. Positions C3, C6 and C9 were also important for antibacterial activity 
(ALBERT et al., 1945). DNA intercalation of some aminoacridines was responsible for 
antibacterial activity and this led to anticancer compounds development (LERMAN, 1963). 
SINGH et al. (2011) synthesized benzotriazole substituted acridines with aim to 
determine their antibacterial activity. Compounds 1a and 1b (Fig. 11) showed moderate 
antibacterial activity, probably due to unsubstituted aromatic amino group, whereas 
compounds 2a and 2b showed good antibacterial activity. These authors suggested that 
presence of -OCH3 or -CH3 at C2 position of acridine ring increased antibacterial activity. 
 
 
 
Figure 11. Compounds with moderate (1a-b) and good (2a-b)  
antibacterial activity. 
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According to KUDRYAVTSEVA et al. (2017), 9-oxoacridines have antibacterial 
properties which are result of DNA intercalation. They synthesized derivatives of 9-
oxoacridines and acridine-9-carboxylic acid which had 5-nitrofurantoin as a substituent. 
Antimicrobial activity of compounds 1 and 3 (Fig. 12) was comparable to standard 
(ethacridine lactate), compound 1 had more potent inhibition effect compared to standard, 
while 4 and 5 showed moderate activity. Compound without 5-nitrofurantoin as a substituent 
(3) had the lowest activity against tested strains. 
 
 
 
Figure 12. Derivatives of 9-oxoacridines and acridine-9-carboxylic acid. 
 
 
 
ANTITUMOR ACTIVITY OF ACRIDINE DERIVATIVES 
 
GAO et al. (1998) conducted quantitative structure-activity relationship analysis 
(QSAR) of 9-anilinoacridines with antitumor activity (including inhibitory activity on tumor 
cells and binding to DNA). They suggested that electronic effects of substituents affected 
drug’s binding site. Hydrophobicity affected the entrance of the drug to the active site and 
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substituent’s steric effects influenced binding to the active site. On the basis of the previous 
work (GAO et al., 1998), Bacherikov et al. (2005) synthesized a series of 5-(9-
acridinylamino)anisidines, such as 5-(9-acridinylamino)-m-anisidines (AMAs), 5-(9-
acridinylamino)-o-anisidines (AOAs) and 5-(9-acridinylamino)-p-anisidines (APAs) (Fig. 
13), in order to investigate inhibition of tumor cell growth in different cell cultures, 
topoisomerase II inhibition and interaction with DNA. 
 
 
 
Figure 13. Structures of 5-(9-acridinylamino)-m-anisidines (AMAs) 1a-e; 5-(9-acridinylamino)-
o-anisidines (AOAs) 2a-e; 5-(9-acridinylamino)-p-anisidines (APAs) 3a-e. 
 
Previous reports (CAIN et al., 1975) showed that -OCH3 group, with electron-donating 
effect on the aniline ring of 9-anilinoacridine derivatives, increased antitumor potency and it 
was suggested that replacing -CH3 group with -OCH3 may increase cytotoxicity of 5-(9-
acridinylamino)toluidines.  
CHANG et al. (2003) showed that 5-(9-acridinyl- amino)toluidine derivatives with -
CONHCH2CH2N(CH3)2 and -CH3 substituents at C4 and C5 of the acridine ring were more 
toxic than the parent AHMA (3-(9-acridinylamino)-5-hydroxymethyl- aniline), in contrast to 
the simple 5-(9-acridinylamino)toluidines. According to these results, it was easy to define 
factors that influence the cytotoxicity of 9-anilinoacridines. 
BACHERIKOV et al. (2005) showed that AOA (2e) (Fig. 13) was the most potent agent 
among tested compounds. These authors also suggested that the drug/DNA binding affinity 
was dominant factor that affects their cytotoxicity. 
LYAKHOV et al. (1997) synthesized acridinyl- amino acids and their methyl esters and 
investigated their cytostatic activity using root test. The polymethylene chain’s length 
influence on the character of the action of synthesized compounds was examined (Fig. 14). 
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Figure 14. Structures of acridinylamino acids and their methyl esters. 
 
Compounds 30 and 31 had stimulatory effect on the cell-division process, but when 
used in higher concentrations they showed depressing effect. Stimulatory effect of compound 
32 was less pronounced, while compounds 33 and 34 had inhibitory effect even in low 
concentrations (LYAKHOV et al., 1997). They also concluded that there were no significant 
differences in cytotoxicity of acridinylamino acids and corresponding methyl esters. 
SONDHI et al. (2010) synthesized and evaluated a series of acridine derivatives (1a-o 
and 2a-g) for anti-inflammatory and anticancer activities. The most active compounds with 
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anticancer activity were 1g and 1m. Compounds 2d, 2f and 2g also showed good anticancer 
activity due to electronic and stereochemical effects of substituents (Fig. 15). 
 
 
 
Figure 15. Acridine derivatives with anti-inflammatory and anticancer activities. 
 
LANG et al. (2013) synthesized a series of acridine derivatives (Fig. 16). They were 
focused on the linker between acridine ring and phenyl group and its effect on the 
antiproliferative activity and DNA-binding ability. Examined cytotoxicity of acridine 
compounds depends on the structure of the linker between acridine ring and phenyl group. 
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The length of the alkyl chain has modest influence on the cytotoxic activity. Compound 1 
with the shortest linker showed better cytotoxicity than compounds 2 and 3, so it was 
suggested that the increase in chain length leads to modest reduction of cytotoxic activity. 
Introduction of alkoxy or acylamino linker decreased antiproliferative activity. Methyl group 
at C4 position and chloro group at C6 position of acridine ring had no obvious effect on the 
activity. Finally, compound 7 with -OCH3 group at C2 position showed greatest cytotoxic 
activity, affecting DNA topoisomerase I inhibition and caspase-dependent intrinsic 
mitochondrial pathway.  
 
 
 
Figure 16. Acridine derivatives with different linker between acridine and benzene ring and 
different substituents on acridine ring. 
 
Effects on DNA synthesis and biochemical pathways, including protein and lipid 
metabolism, suggest that acridine derivatives may be considered as multi-target compounds. 
KUMAR et al. (2013) synthesized a series of 9-aminoacridine derivatives and tested 
their anticancer activity (Fig. 17). Compounds 1 and 2 exhibited good activity against lung 
cancer (A-549) and cervical cancer (HeLa) cell lines. SAR analysis showed that substitution 
by -OCH3 group at position C2 of acridine ring and -CF3 group at position C3 of benzene ring 
attached to the acridine ring resulted in compounds with potent activity against tested cancer 
cell lines. Also, presence of an electron donating group on acridine ring at position C2 
increased anticancer activity. 
DOBRIČIĆ et al. (2016a) designed new acridine derivatives with potential multi-target 
action [DNA intercalation and inhibition of kinases - Src, MEK and VEGFR-2 (CUI et al., 
2016)]. These compounds contain aminoacids (L-glycine, L- and D-phenylalanine, L-histi-
dine and L-asparagine) or corresponding dipeptides in C9 side chain (Fig. 18). Their potential 
to interact with selected targets was tested using molecular docking studies. Obtained results 
showed that binding of designed compounds to DNA, with exception of compounds 3, 4, 5 
and 6, was similar to amsacrine, which was used as standard. Derivatives with lowest binding 
energies that form key binding interactions with MEK were 4, 6, 9, 10, 11, 12, 13, 15, 16, 18 
and 19, with VEGFR-2 were 8, 11 and 16, whereas with Src were 4 and 6. 
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Figure 17. Structure of 9-aminoacridine derivatives tested  
for anticancer activity. 
 
 
 
  
Figure 18. Chemical structures of designed acridines with potential multi-target action. 
 
The same authors designed additional group of 9-aminoacridine derivatives (Fig. 19) 
and examined their interaction with same targets (DNA, Src, MEK and VEGFR-2) using 
molecular docking (DOBRIČIĆ et al., 2016b). 
 
 
 
Figure 19. Additional group of 9-aminoacridine derivatives with potential multi-target action. 
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All compounds showed DNA binding affinity similar to amsacrine. Compounds 3, 4, 
5, 6, 7 and 9 formed significant interactions with MEK, whereas compounds 1, 3, 7 and 8 
showed significant binding to Src. Derivatives 3, 4, 5, 8 and 9 formed some of the important 
interactions with VEGFR-2, but according to their binding energies, moderate activity 
towards VEGFR-2 can be expected. 
 
 
CONCLUSION 
 
Although introduced in 19th century, acridine derivatives are still of scientific interest. 
In this review, acridine derivatives with various biological activity (antiparasitic, antiviral, 
antibacterial and antiproliferative), as well as their structure-activity relationship analyses are 
presented. Although several mechanisms of their action are known, only important are 
discussed here. It can be concluded that dominant mechanisms are DNA intercalation and 
interactions with enzymes. 
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